The therapeutic efficacy of multiple protein kinase inhibitors suggested here has already been demonstrated by less specific protein kinase inhibitors which attack tumors through multiple mechanisms and are used in more than one type of cancer therapy [54]. This evidence concerns the gene WEE1 and cancer.